language_icon
EN
HI

Colinz Laboratories Share price

COLINZ

47.03

1.23 (2.69%)
Last updated on 23 Apr, 2026 | 14:42 IST
Today's High

48.09

Today's Low

46.72

52 Week Low

36.11

52 Week High

87.91

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Colinz Laboratories Chart

Colinz Laboratories Share Key Metrics

Volume
519.00
Market Cap
11.54 CR
LTQ@LTP
100@47.03
ATP
47.07
Var Margin
100 %
Circuit Range
43.51-48.09
Delivery %
100 %
Value
24429.33
ASM/GSM
No
Market Lot
1

Summary

Colinz Laboratories share price stands at ₹47.03 at 23 Apr, 2026 | 14:42. The stock Colinz Laboratories intraday movement has stayed between ₹46.72 and ₹48.09, while on a 52-week basis it has fluctuated from ₹36.11 to ₹87.91.
In terms of trading activity, Colinz Laboratories has recorded a volume of 519 shares. The Colinz Laboratories has a market cap of ₹2519100. The stock’s Average Traded Price (ATP) stands at ₹4707, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 100, 4703.
The Colinz Laboratories operates within a circuit range of ₹43.51-48.09 – ₹43.51-48.09, with a Value of ₹24429.33. The Delivery Percentage for the day is 100%. Additionally, Colinz Laboratories currently falls under the No framework, and trades with a market lot size of 1.

Colinz Laboratories Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

64.21

Sector P/B

3.51

Sec. Div. Yield

0.57

Colinz Laboratories Resistance and Support

Pivot 46.92

Resistance

First Resistance

48.05

Second Resistance

50.29

Third Resistance

51.42

Support

First Support

44.68

Second Support

43.55

Third Support

41.31

Colinz Laboratories Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

66%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

34%

Others

0%

Total Promoters
MAR '26
66%

Colinz Laboratories Corporate Actions

DateAgenda
2026-04-29Quarterly Results
2026-01-24Quarterly Results
2026-01-17Others
2025-11-27Others
2025-11-11Others
2025-11-03Quarterly Results
2025-07-31Quarterly Results
2025-05-16Audited Results
2025-01-31Quarterly Results

Colinz Laboratories News

Colinz Laboratories Ltd - 531210 - Board Meeting Intimation for Notice Of Date Of Board Meeting Pursuant To Regulation 29(2) Of SEBI (LODR) Regulations, 2015.

Colinz Laboratories board to meet on April 29, 2026, to consider and approve its audited financial results for Q4 FY26. The trading window for securities remains closed until after the meeting.
Apr 21 2026 15:04:00

Colinz Laboratories Ltd - 531210 - Confirmation Of Not Being Identified As Large Corporate In Terms Of SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26, 2018 - Fund Raising By Issuance Of Debt Securities By Large Entities

Colinz Laboratories confirms it does not meet the criteria to be identified as a 'Large Corporate' under SEBI regulations. This exempts the company from specific initial and annual disclosure requirements related to debt securities for the financial year ended March 31, 2026.
Apr 03 2026 12:04:00

About Colinz Laboratories

NSE : 0  
BSE : 531210  
ISIN : INE923C01011  

The company was incorporated as a PrIvate Limited Companywith the Registrar of Companies Maharashtra Bombay inOctober 1988 under the name Colinz Laboratories PrivateLimited and converted into a public limited company on 8thNovember 1994 and certificate for change of name was obtainedon 5.1.95. The Company has its existing manufacturIng facilities atRaja Industrial Estate Mulund where it is manufacturIng tabletsand capsules. The company manufactures its liquid oral productson loan licence basis from other manufactures. The companystarted its Manufacturing operations in April 1988 and commencedits marketing operations on a low key with 10 field staff in July1988.The present factory of the company is situated in Raja IndustrialEstate Mulund. The Industrial Estate has a total of 188 galashousing a number of manufacturIng units. The estate has all theinfrastructural facilities.The company owns a gala admeasuring 2000 ft in this estate. Inaddition the company also has taken on lease for a perIod of tenyears from Mr. L.S. Mani the chief promoter another gala in thesame industrial estate admeasuring 422 sq ft. with an additionalopen terrace of 578 sq.fi. on a deposit of Rs. 10 lacs and monthlylease rent of Rs. 3000 with an annual increase of 10% in themonthly compensation amount.The Company markets it products through ethical sales throughthe chain of Regional Managers/Area Managers/ Medical SalesRepresentatives (MSRs) and Stockists. Marketing activities werekept at a low key until 1991-92 considering the expensesrequired to be incurred in consumer marketing and particularly inethical pharmaceutical selling where samples to the doctors andsalaries to the sales staff are of high order. However theCompany took a bold decision to operate with at least certainlimited areas from 1991-92 and it established a network of 50Medical Representatives and about 10 managers. Therefore inthe real sense reasonable size of marketing operations werestarted by the Company only in 1991-92.During the year 1992-93 and 1993-94 the Company tested thecapacity of its field strength by marketing high volume low marginproducts. The company registered substantial jump in sales inthese two years with operations in a very limited area and withthe help of only 50 MSRs.The company''s main formulations are for Gynecologicalapplications. The company''s main product "Pantoplex" is wellaccepted and enjoys considerable market share in the areasalready being marketed and accounts for 50% of the currentturnover of the company.

Read More

Colinz Laboratories Management

NamePosition
Falguni KumawatCompany Secretary & Compliance Officer
N K MenonWhole Time Director
View More

Colinz Laboratories FAQs

The Buying Price of Colinz Laboratories share is 47.03 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Colinz Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Colinz Laboratories, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Colinz Laboratories shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Colinz Laboratories shares is 0. Useful to assess the stock's value relative to its book value.

To assess Colinz Laboratories’s valuation compare Sector P/E, P/B which are 64.21 & 3.51 with sector averages, along with growth rates and financial metrics.

The Market Cap of Colinz Laboratories is 11.54 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Colinz Laboratories share price is 87.91 & 36.11. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Colinz Laboratories belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost